0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global OTC Eyedrop Market Research Report 2026
Published Date: 2026-04-29
|
Report Code: QYRE-Auto-28N17982
Home | Market Reports | Health| Vision Care
Global OTC Eyedrop Market Research Report 2024
BUY CHAPTERS

Global OTC Eyedrop Market Research Report 2026

Code: QYRE-Auto-28N17982
Report
2026-04-29
Pages:121
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

OTC Eyedrop Market Size

The global OTC Eyedrop market was valued at US$ 4032 million in 2025 and is anticipated to reach US$ 5947 million by 2032, at a CAGR of 5.8% from 2026 to 2032.

OTC Eyedrop Market

OTC Eyedrop Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on OTC Eyedrop competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
OTC (over-the-counter) eyedrops are non-prescription eye solutions used to relieve various common eye issues such as dryness, redness, itching, and irritation. These drops are readily available without the need for a doctor’s prescription and often used for temporary relief of symptoms caused by allergies, environmental factors, or prolonged screen use. OTC eyedrops come in different types, including artificial tears for lubrication, decongestants to reduce redness, and antihistamines to treat allergy-related itching. Some formulations are preservative-free, making them suitable for sensitive eyes or frequent.
One of the key drivers of the OTC eyedrop market is the increasing prevalence of eye conditions such as dry eye syndrome, eye allergies, and irritation caused by prolonged screen time and environmental factors. With more people using digital devices for extended periods, demand for eyedrops to relieve discomfort and provide moisture has surged. Additionally, the aging population is contributing to the growth of this market, as older adults are more likely to experience eye issues, making OTC solutions a convenient, accessible option for symptom relief.
A significant challenge in the OTC eyedrop market is the potential for consumer confusion and misuse. With a wide variety of products available, including drops for dry eyes, redness, and allergies, consumers may struggle to choose the right formulation for their needs. Misuse or overuse of certain products, especially those containing preservatives or vasoconstrictors, can lead to adverse effects, such as increased eye irritation or dependency. This challenge is compounded by the presence of counterfeit or substandard products, which can further erode consumer confidence.
Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Santen Pharma, CooperVision, Zhenshiming are the key manufactures in the global OTC Eyedrop market. Among them, Alcon is the largest manufacturer, its revenue share of global market exceeds 21.76% in 2023. The market concentration is high, and top five players accounted for about 60.87% of the world's revenue share.
This report delivers a comprehensive overview of the global OTC Eyedrop market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding OTC Eyedrop. The OTC Eyedrop market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global OTC Eyedrop market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist OTC Eyedrop manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of OTC Eyedrop Market Report

Report Metric Details
Report Name OTC Eyedrop Market
Accounted market size in 2025 US$ 4032 million
Forecasted market size in 2032 US$ 5947 million
CAGR 5.8%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Contact Lenses Eyedrop
  • Allergy Eyedrop
  • Dry Eye Drop
  • Others
by Application
  • Online Pharmacies
  • Retail Pharmacies
  • Hospital Pharmacies
  • Optical Channel
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Santen Pharma, CooperVision, Zhengshiming
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for OTC Eyedrop manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines OTC Eyedrop sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is OTC Eyedrop Market growing?

Ans: The OTC Eyedrop Market witnessing a CAGR of 5.8% during the forecast period 2026-2032.

What is the OTC Eyedrop Market size in 2032?

Ans: The OTC Eyedrop Market size in 2032 will be US$ 5947 million.

What is the Alcon share in OTC Eyedrop Market?

Ans: Among them, Alcon is the largest manufacturer, its revenue share of global market exceeds 21.76% in 2023.

What is the market share of major companies in OTC Eyedrop Market?

Ans: The market concentration is high, and top five players accounted for about 60.87% of the world's revenue share.

Who are the main players in the OTC Eyedrop Market report?

Ans: The main players in the OTC Eyedrop Market are Alcon, AbbVie, Thea pharmaceuticals, Bausch Health, URSAPHARM, OmniVision Pharma, Rohto, Prestige Consumer Healthcare, LION, Kenvue (VISINE), Santen Pharma, CooperVision, Zhengshiming

What are the Application segmentation covered in the OTC Eyedrop Market report?

Ans: The Applications covered in the OTC Eyedrop Market report are Online Pharmacies, Retail Pharmacies, Hospital Pharmacies, Optical Channel

What are the Type segmentation covered in the OTC Eyedrop Market report?

Ans: The Types covered in the OTC Eyedrop Market report are Contact Lenses Eyedrop, Allergy Eyedrop, Dry Eye Drop, Others

1 OTC Eyedrop Market Overview
1.1 Product Definition
1.2 OTC Eyedrop by Type
1.2.1 Global OTC Eyedrop Market Value by Type: 2025 vs 2032
1.2.2 Contact Lenses Eyedrop
1.2.3 Allergy Eyedrop
1.2.4 Dry Eye Drop
1.2.5 Others
1.3 OTC Eyedrop by Application
1.3.1 Global OTC Eyedrop Market Value by Application: 2025 vs 2032
1.3.2 Online Pharmacies
1.3.3 Retail Pharmacies
1.3.4 Hospital Pharmacies
1.3.5 Optical Channel
1.4 Global OTC Eyedrop Market Size Estimates and Forecasts
1.4.1 Global OTC Eyedrop Revenue 2021–2032
1.4.2 Global OTC Eyedrop Sales 2021–2032
1.4.3 Global OTC Eyedrop Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 OTC Eyedrop Market Competition by Manufacturers
2.1 Global OTC Eyedrop Sales Market Share by Manufacturers (2021–2026)
2.2 Global OTC Eyedrop Revenue Market Share by Manufacturers (2021–2026)
2.3 Global OTC Eyedrop Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of OTC Eyedrop, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of OTC Eyedrop, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of OTC Eyedrop, Product Types and Applications
2.7 Global Key Manufacturers of OTC Eyedrop, Date of Entry into the Industry
2.8 Global OTC Eyedrop Market Competitive Situation and Trends
2.8.1 Global OTC Eyedrop Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global OTC Eyedrop Players Market Share by Revenue
2.8.3 Global OTC Eyedrop Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global OTC Eyedrop Market Scenario by Region
3.1 Global OTC Eyedrop Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global OTC Eyedrop Sales by Region: 2021–2032
3.2.1 Global OTC Eyedrop Sales by Region: 2021–2026
3.2.2 Global OTC Eyedrop Sales by Region: 2027–2032
3.3 Global OTC Eyedrop Revenue by Region: 2021–2032
3.3.1 Global OTC Eyedrop Revenue by Region: 2021–2026
3.3.2 Global OTC Eyedrop Revenue by Region: 2027–2032
3.4 North America OTC Eyedrop Market Facts & Figures by Country
3.4.1 North America OTC Eyedrop Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America OTC Eyedrop Sales by Country (2021–2032)
3.4.3 North America OTC Eyedrop Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe OTC Eyedrop Market Facts & Figures by Country
3.5.1 Europe OTC Eyedrop Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe OTC Eyedrop Sales by Country (2021–2032)
3.5.3 Europe OTC Eyedrop Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific OTC Eyedrop Market Facts & Figures by Region
3.6.1 Asia Pacific OTC Eyedrop Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific OTC Eyedrop Sales by Region (2021–2032)
3.6.3 Asia Pacific OTC Eyedrop Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America OTC Eyedrop Market Facts & Figures by Country
3.7.1 Latin America OTC Eyedrop Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America OTC Eyedrop Sales by Country (2021–2032)
3.7.3 Latin America OTC Eyedrop Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa OTC Eyedrop Market Facts & Figures by Country
3.8.1 Middle East and Africa OTC Eyedrop Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa OTC Eyedrop Sales by Country (2021–2032)
3.8.3 Middle East and Africa OTC Eyedrop Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global OTC Eyedrop Sales by Type (2021–2032)
4.1.1 Global OTC Eyedrop Sales by Type (2021–2026)
4.1.2 Global OTC Eyedrop Sales by Type (2027–2032)
4.1.3 Global OTC Eyedrop Sales Market Share by Type (2021–2032)
4.2 Global OTC Eyedrop Revenue by Type (2021–2032)
4.2.1 Global OTC Eyedrop Revenue by Type (2021–2026)
4.2.2 Global OTC Eyedrop Revenue by Type (2027–2032)
4.2.3 Global OTC Eyedrop Revenue Market Share by Type (2021–2032)
4.3 Global OTC Eyedrop Price by Type (2021–2032)
5 Segment by Application
5.1 Global OTC Eyedrop Sales by Application (2021–2032)
5.1.1 Global OTC Eyedrop Sales by Application (2021–2026)
5.1.2 Global OTC Eyedrop Sales by Application (2027–2032)
5.1.3 Global OTC Eyedrop Sales Market Share by Application (2021–2032)
5.2 Global OTC Eyedrop Revenue by Application (2021–2032)
5.2.1 Global OTC Eyedrop Revenue by Application (2021–2026)
5.2.2 Global OTC Eyedrop Revenue by Application (2027–2032)
5.2.3 Global OTC Eyedrop Revenue Market Share by Application (2021–2032)
5.3 Global OTC Eyedrop Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Alcon
6.1.1 Alcon Company Information
6.1.2 Alcon Description and Business Overview
6.1.3 Alcon OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Alcon OTC Eyedrop Product Portfolio
6.1.5 Alcon Recent Developments/Updates
6.2 AbbVie
6.2.1 AbbVie Company Information
6.2.2 AbbVie Description and Business Overview
6.2.3 AbbVie OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 AbbVie OTC Eyedrop Product Portfolio
6.2.5 AbbVie Recent Developments/Updates
6.3 Thea pharmaceuticals
6.3.1 Thea pharmaceuticals Company Information
6.3.2 Thea pharmaceuticals Description and Business Overview
6.3.3 Thea pharmaceuticals OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 Thea pharmaceuticals OTC Eyedrop Product Portfolio
6.3.5 Thea pharmaceuticals Recent Developments/Updates
6.4 Bausch Health
6.4.1 Bausch Health Company Information
6.4.2 Bausch Health Description and Business Overview
6.4.3 Bausch Health OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Bausch Health OTC Eyedrop Product Portfolio
6.4.5 Bausch Health Recent Developments/Updates
6.5 URSAPHARM
6.5.1 URSAPHARM Company Information
6.5.2 URSAPHARM Description and Business Overview
6.5.3 URSAPHARM OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 URSAPHARM OTC Eyedrop Product Portfolio
6.5.5 URSAPHARM Recent Developments/Updates
6.6 OmniVision Pharma
6.6.1 OmniVision Pharma Company Information
6.6.2 OmniVision Pharma Description and Business Overview
6.6.3 OmniVision Pharma OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 OmniVision Pharma OTC Eyedrop Product Portfolio
6.6.5 OmniVision Pharma Recent Developments/Updates
6.7 Rohto
6.7.1 Rohto Company Information
6.7.2 Rohto Description and Business Overview
6.7.3 Rohto OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Rohto OTC Eyedrop Product Portfolio
6.7.5 Rohto Recent Developments/Updates
6.8 Prestige Consumer Healthcare
6.8.1 Prestige Consumer Healthcare Company Information
6.8.2 Prestige Consumer Healthcare Description and Business Overview
6.8.3 Prestige Consumer Healthcare OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Prestige Consumer Healthcare OTC Eyedrop Product Portfolio
6.8.5 Prestige Consumer Healthcare Recent Developments/Updates
6.9 LION
6.9.1 LION Company Information
6.9.2 LION Description and Business Overview
6.9.3 LION OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 LION OTC Eyedrop Product Portfolio
6.9.5 LION Recent Developments/Updates
6.10 Kenvue (VISINE)
6.10.1 Kenvue (VISINE) Company Information
6.10.2 Kenvue (VISINE) Description and Business Overview
6.10.3 Kenvue (VISINE) OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 Kenvue (VISINE) OTC Eyedrop Product Portfolio
6.10.5 Kenvue (VISINE) Recent Developments/Updates
6.11 Santen Pharma
6.11.1 Santen Pharma Company Information
6.11.2 Santen Pharma Description and Business Overview
6.11.3 Santen Pharma OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Santen Pharma OTC Eyedrop Product Portfolio
6.11.5 Santen Pharma Recent Developments/Updates
6.12 CooperVision
6.12.1 CooperVision Company Information
6.12.2 CooperVision Description and Business Overview
6.12.3 CooperVision OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 CooperVision OTC Eyedrop Product Portfolio
6.12.5 CooperVision Recent Developments/Updates
6.13 Zhengshiming
6.13.1 Zhengshiming Company Information
6.13.2 Zhengshiming Description and Business Overview
6.13.3 Zhengshiming OTC Eyedrop Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 Zhengshiming OTC Eyedrop Product Portfolio
6.13.5 Zhengshiming Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 OTC Eyedrop Industry Chain Analysis
7.2 OTC Eyedrop Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 OTC Eyedrop Production Mode & Process Analysis
7.4 OTC Eyedrop Sales and Marketing
7.4.1 OTC Eyedrop Sales Channels
7.4.2 OTC Eyedrop Distributors
7.5 OTC Eyedrop Customer Analysis
8 OTC Eyedrop Market Dynamics
8.1 OTC Eyedrop Industry Trends
8.2 OTC Eyedrop Market Drivers
8.3 OTC Eyedrop Market Challenges
8.4 OTC Eyedrop Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global OTC Eyedrop Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global OTC Eyedrop Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global OTC Eyedrop Market Competitive Situation by Manufacturers in 2025
 Table 4. Global OTC Eyedrop Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global OTC Eyedrop Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global OTC Eyedrop Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global OTC Eyedrop Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market OTC Eyedrop Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of OTC Eyedrop, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of OTC Eyedrop, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of OTC Eyedrop, Product Types and Applications
 Table 12. Global Key Manufacturers of OTC Eyedrop, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global OTC Eyedrop Companies by Tier (Tier 1, Tier 2, Tier 3), based on OTC Eyedrop Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global OTC Eyedrop Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global OTC Eyedrop Sales by Region (K Units), 2021–2026
 Table 18. Global OTC Eyedrop Sales Market Share by Region (2021–2026)
 Table 19. Global OTC Eyedrop Sales by Region (K Units), 2027–2032
 Table 20. Global OTC Eyedrop Sales Market Share by Region (2027–2032)
 Table 21. Global OTC Eyedrop Revenue by Region (US$ Million), 2021–2026
 Table 22. Global OTC Eyedrop Revenue Market Share by Region (2021–2026)
 Table 23. Global OTC Eyedrop Revenue by Region (US$ Million), 2027–2032
 Table 24. Global OTC Eyedrop Revenue Market Share by Region (2027–2032)
 Table 25. North America OTC Eyedrop Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America OTC Eyedrop Sales by Country (K Units), 2021–2026
 Table 27. North America OTC Eyedrop Sales by Country (K Units), 2027–2032
 Table 28. North America OTC Eyedrop Revenue by Country (US$ Million), 2021–2026
 Table 29. North America OTC Eyedrop Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe OTC Eyedrop Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe OTC Eyedrop Sales by Country (K Units), 2021–2026
 Table 32. Europe OTC Eyedrop Sales by Country (K Units), 2027–2032
 Table 33. Europe OTC Eyedrop Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe OTC Eyedrop Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific OTC Eyedrop Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific OTC Eyedrop Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific OTC Eyedrop Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific OTC Eyedrop Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific OTC Eyedrop Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America OTC Eyedrop Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America OTC Eyedrop Sales by Country (K Units), 2021–2026
 Table 42. Latin America OTC Eyedrop Sales by Country (K Units), 2027–2032
 Table 43. Latin America OTC Eyedrop Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America OTC Eyedrop Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa OTC Eyedrop Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa OTC Eyedrop Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa OTC Eyedrop Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa OTC Eyedrop Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa OTC Eyedrop Revenue by Country (US$ Million), 2027–2032
 Table 50. Global OTC Eyedrop Sales (K Units) by Type (2021–2026)
 Table 51. Global OTC Eyedrop Sales (K Units) by Type (2027–2032)
 Table 52. Global OTC Eyedrop Sales Market Share by Type (2021–2026)
 Table 53. Global OTC Eyedrop Sales Market Share by Type (2027–2032)
 Table 54. Global OTC Eyedrop Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global OTC Eyedrop Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global OTC Eyedrop Revenue Market Share by Type (2021–2026)
 Table 57. Global OTC Eyedrop Revenue Market Share by Type (2027–2032)
 Table 58. Global OTC Eyedrop Price (US$/Unit) by Type (2021–2026)
 Table 59. Global OTC Eyedrop Price (US$/Unit) by Type (2027–2032)
 Table 60. Global OTC Eyedrop Sales (K Units) by Application (2021–2026)
 Table 61. Global OTC Eyedrop Sales (K Units) by Application (2027–2032)
 Table 62. Global OTC Eyedrop Sales Market Share by Application (2021–2026)
 Table 63. Global OTC Eyedrop Sales Market Share by Application (2027–2032)
 Table 64. Global OTC Eyedrop Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global OTC Eyedrop Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global OTC Eyedrop Revenue Market Share by Application (2021–2026)
 Table 67. Global OTC Eyedrop Revenue Market Share by Application (2027–2032)
 Table 68. Global OTC Eyedrop Price (US$/Unit) by Application (2021–2026)
 Table 69. Global OTC Eyedrop Price (US$/Unit) by Application (2027–2032)
 Table 70. Alcon Company Information
 Table 71. Alcon Description and Business Overview
 Table 72. Alcon OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Alcon OTC Eyedrop Product
 Table 74. Alcon Recent Developments/Updates
 Table 75. AbbVie Company Information
 Table 76. AbbVie Description and Business Overview
 Table 77. AbbVie OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. AbbVie OTC Eyedrop Product
 Table 79. AbbVie Recent Developments/Updates
 Table 80. Thea pharmaceuticals Company Information
 Table 81. Thea pharmaceuticals Description and Business Overview
 Table 82. Thea pharmaceuticals OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. Thea pharmaceuticals OTC Eyedrop Product
 Table 84. Thea pharmaceuticals Recent Developments/Updates
 Table 85. Bausch Health Company Information
 Table 86. Bausch Health Description and Business Overview
 Table 87. Bausch Health OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Bausch Health OTC Eyedrop Product
 Table 89. Bausch Health Recent Developments/Updates
 Table 90. URSAPHARM Company Information
 Table 91. URSAPHARM Description and Business Overview
 Table 92. URSAPHARM OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. URSAPHARM OTC Eyedrop Product
 Table 94. URSAPHARM Recent Developments/Updates
 Table 95. OmniVision Pharma Company Information
 Table 96. OmniVision Pharma Description and Business Overview
 Table 97. OmniVision Pharma OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. OmniVision Pharma OTC Eyedrop Product
 Table 99. OmniVision Pharma Recent Developments/Updates
 Table 100. Rohto Company Information
 Table 101. Rohto Description and Business Overview
 Table 102. Rohto OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Rohto OTC Eyedrop Product
 Table 104. Rohto Recent Developments/Updates
 Table 105. Prestige Consumer Healthcare Company Information
 Table 106. Prestige Consumer Healthcare Description and Business Overview
 Table 107. Prestige Consumer Healthcare OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Prestige Consumer Healthcare OTC Eyedrop Product
 Table 109. Prestige Consumer Healthcare Recent Developments/Updates
 Table 110. LION Company Information
 Table 111. LION Description and Business Overview
 Table 112. LION OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. LION OTC Eyedrop Product
 Table 114. LION Recent Developments/Updates
 Table 115. Kenvue (VISINE) Company Information
 Table 116. Kenvue (VISINE) Description and Business Overview
 Table 117. Kenvue (VISINE) OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. Kenvue (VISINE) OTC Eyedrop Product
 Table 119. Kenvue (VISINE) Recent Developments/Updates
 Table 120. Santen Pharma Company Information
 Table 121. Santen Pharma Description and Business Overview
 Table 122. Santen Pharma OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Santen Pharma OTC Eyedrop Product
 Table 124. Santen Pharma Recent Developments/Updates
 Table 125. CooperVision Company Information
 Table 126. CooperVision Description and Business Overview
 Table 127. CooperVision OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. CooperVision OTC Eyedrop Product
 Table 129. CooperVision Recent Developments/Updates
 Table 130. Zhengshiming Company Information
 Table 131. Zhengshiming Description and Business Overview
 Table 132. Zhengshiming OTC Eyedrop Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. Zhengshiming OTC Eyedrop Product
 Table 134. Zhengshiming Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. OTC Eyedrop Distributors List
 Table 138. OTC Eyedrop Customers List
 Table 139. OTC Eyedrop Market Trends
 Table 140. OTC Eyedrop Market Drivers
 Table 141. OTC Eyedrop Market Challenges
 Table 142. OTC Eyedrop Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of OTC Eyedrop
 Figure 2. Global OTC Eyedrop Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global OTC Eyedrop Market Share by Type: 2025 & 2032
 Figure 4. Contact Lenses Eyedrop Product Picture
 Figure 5. Allergy Eyedrop Product Picture
 Figure 6. Dry Eye Drop Product Picture
 Figure 7. Others Product Picture
 Figure 8. Global OTC Eyedrop Market Value by Application (US$ Million), 2021–2032
 Figure 9. Global OTC Eyedrop Market Share by Application: 2025 & 2032
 Figure 10. Online Pharmacies
 Figure 11. Retail Pharmacies
 Figure 12. Hospital Pharmacies
 Figure 13. Optical Channel
 Figure 14. Global OTC Eyedrop Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 15. Global OTC Eyedrop Market Size (US$ Million), 2021–2032
 Figure 16. Global OTC Eyedrop Sales (K Units), 2021–2032
 Figure 17. Global OTC Eyedrop Average Price (US$/Unit), 2021–2032
 Figure 18. OTC Eyedrop Report Years Considered
 Figure 19. OTC Eyedrop Sales Share by Manufacturers in 2025
 Figure 20. Global OTC Eyedrop Revenue Share by Manufacturers in 2025
 Figure 21. Top 5 and Top 10 Global OTC Eyedrop Players: Market Share by Revenue in OTC Eyedrop in 2025
 Figure 22. OTC Eyedrop Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 23. Global OTC Eyedrop Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 24. North America OTC Eyedrop Sales Market Share by Country (2021–2032)
 Figure 25. North America OTC Eyedrop Revenue Market Share by Country (2021–2032)
 Figure 26. United States OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 27. Canada OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 28. Europe OTC Eyedrop Sales Market Share by Country (2021–2032)
 Figure 29. Europe OTC Eyedrop Revenue Market Share by Country (2021–2032)
 Figure 30. Germany OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. France OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. U.K. OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Italy OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 34. Russia OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 35. Asia Pacific OTC Eyedrop Sales Market Share by Region (2021–2032)
 Figure 36. Asia Pacific OTC Eyedrop Revenue Market Share by Region (2021–2032)
 Figure 37. China OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. Japan OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. South Korea OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. India OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Australia OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. China Taiwan OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 43. Southeast Asia OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 44. Latin America OTC Eyedrop Sales Market Share by Country (2021–2032)
 Figure 45. Latin America OTC Eyedrop Revenue Market Share by Country (2021–2032)
 Figure 46. Mexico OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Brazil OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Argentina OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 49. Colombia OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 50. Middle East and Africa OTC Eyedrop Sales Market Share by Country (2021–2032)
 Figure 51. Middle East and Africa OTC Eyedrop Revenue Market Share by Country (2021–2032)
 Figure 52. Turkey OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Saudi Arabia OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 54. UAE OTC Eyedrop Revenue Growth Rate (US$ Million), 2021–2032
 Figure 55. Global Sales Market Share of OTC Eyedrop by Type (2021–2032)
 Figure 56. Global Revenue Market Share of OTC Eyedrop by Type (2021–2032)
 Figure 57. Global OTC Eyedrop Price (US$/Unit) by Type (2021–2032)
 Figure 58. Global Sales Market Share of OTC Eyedrop by Application (2021–2032)
 Figure 59. Global Revenue Market Share of OTC Eyedrop by Application (2021–2032)
 Figure 60. Global OTC Eyedrop Price (US$/Unit) by Application (2021–2032)
 Figure 61. OTC Eyedrop Value Chain
 Figure 62. Channels of Distribution (Direct Vs Distribution)
 Figure 63. Bottom-up and Top-down Approaches for This Report
 Figure 64. Data Triangulation
 Figure 65. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Samsung SD